Mode
Text Size
Log in / Sign up

Hospital-acquired infections associated with higher costs and length of stay in discharged cancer center patientsHidden Costs of Hospital Infections Under New Payment Rules

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret findings cautiously as retrospective data links infections to higher costs and longer stays without reported effect sizes.

This retrospective cohort study evaluated discharged patients at a regional cancer center with conditions including cancer-related nosocomial infections and malignant neoplasm of thoracic esophagus. The sample size was not reported. Patients were categorized by exposure to hospital-acquired infections compared against non-HAI patients. Follow-up duration was not reported.

The infected group demonstrated significantly higher DIP deficits, hospitalization costs, and diagnostic test and procedure costs compared to the comparator group, with p < 0.05 reported for all comparisons. Length of stay was also longer in the infected group, achieving statistical significance at p < 0.05. Additionally, MDRO type count positively correlated with hospitalization costs, diagnostic test and procedure costs, length of stay, and DIP deficits, where p < 0.05. Surgical site wound contamination grade similarly showed positive correlation with hospitalization costs, diagnostic test and procedure costs, length of stay, and DIP deficits, with p < 0.05.

Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported. The study limitations section was empty. Funding or conflicts of interest were not reported. Practice relevance was not reported. Causality and certainty notes were not reported.

Clinicians should interpret these findings cautiously given the observational nature of the retrospective cohort study. Absolute numbers and effect sizes were not reported, limiting the assessment of clinical magnitude. The lack of sample size and follow-up details further constrains generalizability to other settings.

Hidden Costs of Hospital Infections Under New Payment Rules

Getting sick in the hospital is scary enough. But getting a new infection while you are already fighting cancer adds a heavy financial weight. A new study looks at how these hospital-acquired infections change the cost of care under China's latest payment system.

Cancer treatment is already expensive. Patients often worry about the bill before they even get their first dose of medicine. Now, hospitals are using a new way to get paid called the Diagnosis-Intervention Packet model.

This system groups similar treatments into one package with a fixed price. It is meant to stop hospitals from doing unnecessary tests or keeping patients too long. But what happens when a patient gets a new infection inside the hospital?

Infections like pneumonia or wound infections are common in cancer care. They happen because the immune system is weak. These infections make patients sicker and need more time in the hospital.

The surprising shift

For years, doctors worried that this new payment model would hurt hospitals financially. They feared it would lead to less care for complex patients. This study looked at real data from 2024 to see the truth.

The results were clear. Patients who got infections did cost more money. They needed more tests, more procedures, and more days in the hospital. The hospital lost money on these cases under the new rules.

But here is the twist. The study found that the type of infection mattered. Some infections were much more expensive than others. The place where the infection happened also changed the cost.

What scientists didn't expect

You might think all infections are the same. But this is not true. A simple wound infection costs less than a severe infection with resistant bacteria.

The study used a simple analogy. Think of the hospital payment like a grocery budget. You have a set amount of money for a specific meal. If you get a stomach bug, you need new food and medicine. That eats into your budget.

If the bug is a super-bug that needs special drugs, the cost goes up even faster. The study found that infections with resistant bacteria were the biggest financial drain. These bugs are hard to kill and need expensive treatments.

The study snapshot

Researchers looked at data from a large cancer center. They studied patients who were discharged in 2024. They compared those with infections to those without infections.

They focused on a specific surgery for esophageal cancer. This surgery involves three cuts in the body. It is a major operation. The study found that infections after this surgery were the most common and costly.

They adjusted the data to make sure the results were fair. They looked at many factors to find the real cause of the extra costs.

The numbers tell a clear story. Patients with infections spent much more money. They stayed in the hospital longer. They had more diagnostic tests and procedures.

The study showed that the financial loss was linked to the severity of the infection. The more types of resistant bacteria found, the higher the cost. The dirtier the wound, the higher the cost.

This means that preventing these infections is not just about health. It is also about saving money. Every day a patient stays longer due to an infection costs the system more.

This doesn't mean this treatment is available yet.

The study is about understanding costs, not testing a new drug. It shows that the current system struggles with these infections.

Doctors know that preventing infections is hard. Cancer patients are very vulnerable. Their bodies are fighting a war against cancer. Adding an infection makes the war harder to win.

The study fits into a bigger picture of healthcare reform. The new payment model wants to save money. But infections throw a wrench in the works. Experts say that better infection control is the only way to fix this.

Without better prevention, hospitals will keep losing money on these cases. This could lead to fewer resources for other patients.

If you or a loved one has cancer, know that infections are a real risk. They can happen after surgery or during chemotherapy. If an infection starts, talk to your doctor immediately.

Early treatment can stop the infection from getting worse. This saves money and keeps you healthier. Do not ignore signs of infection like fever or redness at the wound site.

You can also ask about infection prevention steps. Hospitals should have plans to keep patients safe. Knowing your rights helps you stay safe.

This study has some limits. It looked at one cancer center. The results might be different at other hospitals. The data was from 2024, so it is very new.

Also, the study looked at costs, not how well patients felt. Money is important, but quality of life matters more. More research is needed to understand the full picture.

What happens next? Hospitals will need to change how they prevent infections. They must find ways to keep patients safe without breaking the bank.

New trials might test better antibiotics or cleaning methods. It will take time to see if these changes work. The payment model will likely stay the same, but the rules for infection control will get stricter.

Patients and families should stay informed. Ask questions about infection risks before any surgery. Stay up to date on the latest guidelines.

Healthcare is a team effort. Doctors, nurses, and patients must work together. Only then can we reduce infections and save money. The goal is better care for everyone.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundThis study aimed to analyze the distribution and economic burden of cancer-related nosocomial infections under the Diagnosis-Intervention Packet (DIP) payment model.MethodsA retrospective study was conducted using 2024 medical insurance and healthcare-associated infection (HAI) data from discharged patients at a regional cancer center. We compared the differences in medical insurance settlement indicators between HAI and non-HAI patients within major DIP categories, as well as among different HAI types. After adjusting for time-dependent bias and confounding factors via risk-set matching, we further compared the above indicators between HAI and non-HAI patients, and generalized linear model (GLM) was used to identify independent factors for DIP settlement difference.ResultsHAIs were most concentrated in the DIP category Malignant neoplasm of thoracic esophagus: Partial esophagectomy via cervical-thoracic-abdominal three-incision approach. With major DIP categories, the infected group had significantly higher hospitalization costs, diagnostic test and procedure costs, longer length of stay, and greater DIP deficits (all p < 0.05). MDRO type count and surgical site wound contamination grade were positively correlated with the above indicators and DIP deficits (all p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.